granted
on 03 May 2024
Last Applicant/ Owned by
230 Park Avenue, Suite 3350
New York
NY
10169
Serial Number
98033275 filed on 08th Jun 2023
Registration Number
N/A
Correspondent Address
Andrew N. Spivak
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; Industrial analysis and researc Read More
Research and development services in the field of antibodies; Research and development services in the field of antibody technology; Laboratory research and analysis in the field of the production of antibodies; scientific and technological services, namely, scientific research, analysis, and testing in the field of oncology, chemotherapy, and inflammatory diseases; Industrial analysis and research services in the field of chemistry
N/A
N/A
Pharmaceutical preparations and substances for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer
N/A
N/A
No 98033275
No Service Mark
No 26418
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
20th Jun 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
04th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
03rd May 2024 | SOU EXTENSION 1 FILED |
03rd May 2024 | SOU EXTENSION 1 GRANTED |
03rd May 2024 | SOU TEAS EXTENSION RECEIVED |
14th Nov 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
19th Sep 2023 | PUBLISHED FOR OPPOSITION |
19th Sep 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th Aug 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
11th Aug 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |